A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
Public ClinicalTrials.gov record NCT01131013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this early-stage clinical study is to demonstrate an effect of single doses of CK-2017357 on measures of skeletal muscle function and fatigability in patients with peripheral artery disease and symptomatic claudication.
Study identification
- NCT ID
- NCT01131013
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 61 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Mar 2011 (Actual)
- Completion
- Mar 2011 (Actual)
- Last update posted
- May 14, 2019
2010 – 2011
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tatum Ridge Internal Medicine | Phoenix | Arizona | 85032 | — |
| Apex Research Institute | Santa Ana | California | 92705 | — |
| Stanford Hospital and Clinics | Stanford | California | 94305 | — |
| Denver Health Medical Center | Denver | Colorado | 80204 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| DMI Research, Inc | Pinellas Park | Florida | 33782 | — |
| Maine Research Associates | Auburn | Maine | 04210 | — |
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| National Clinical Research - Norfolk, Inc. | Norfolk | Virginia | 23502 | — |
| National Clinical Research - Richmond, Inc. | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01131013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01131013 live on ClinicalTrials.gov.